These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17192148)

  • 1. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.
    Negredo E; Higueras C; Adell X; Martinez JC; Martinez E; Puig J; Fumaz CR; Muñoz-Moreno JA; Perez-Alvarez N; Videla S; Estany C; Cinquegrana D; Gonzalez-Mestre V; Clotet B
    AIDS Patient Care STDS; 2006 Dec; 20(12):829-37. PubMed ID: 17192148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of facial lipoatrophy in HIV-infected patients.
    Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients.
    Negredo E; Puig J; Ornelas A; Echeverría P; Bonjoch A; Estany C; Higueras C; Gonzalez-Mestre V; Clotet B
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):817-21. PubMed ID: 25858612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE].
    Lafaurie M; Dolivo M; Girard PM; May T; Bouchaud O; Carbonnel E; Madelaine I; Loze B; Porcher R; Molina JM;
    HIV Med; 2013 Aug; 14(7):410-20. PubMed ID: 23432777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study.
    Guaraldi G; Orlando G; De Fazio D; De Lorenzi I; Rottino A; De Santis G; Pedone A; Spaggiari A; Baccarani A; Borghi V; Esposito R
    Antivir Ther; 2005; 10(6):753-9. PubMed ID: 16218175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.
    Burgess CM; Quiroga RM
    J Am Acad Dermatol; 2005 Feb; 52(2):233-9. PubMed ID: 15692467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy.
    Cattelan AM; Bauer U; Trevenzoli M; Sasset L; Campostrini S; Facchin C; Pagiaro E; Gerzeli S; Cadrobbi P; Chiarelli A
    Arch Dermatol; 2006 Mar; 142(3):329-34. PubMed ID: 16549708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy.
    Negredo E; Puig J; Aldea D; Medina M; Estany C; Pérez-Alvarez N; Rodríguez-Fumaz C; Muñoz-Moreno JA; Higueras C; Gonzalez-Mestre V; Clotet B
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):451-5. PubMed ID: 19320569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
    HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
    Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-year study of a polyacrylamide hydrogel-based filler for rehabilitation of HIV-related facial lipoatrophy.
    Rauso R
    Aesthet Surg J; 2015 Nov; 35(8):1021-9. PubMed ID: 25953480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous fat grafting and injectable dermal fillers for human immunodeficiency virus-associated facial lipodystrophy: a comparison of safety, efficacy, and long-term treatment outcomes.
    Shuck J; Iorio ML; Hung R; Davison SP
    Plast Reconstr Surg; 2013 Mar; 131(3):499-506. PubMed ID: 23142937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study.
    Mole B; Gillaizeau F; Carbonnel E; Pierre I; Brazille P; Grataloup C; Mercier S; Duracinsky M; Weiss L; Piketty C
    AIDS Res Hum Retroviruses; 2012 Mar; 28(3):251-8. PubMed ID: 21801082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study.
    Mest DR; Humble GM
    Dermatol Surg; 2009 Feb; 35 Suppl 1():350-9. PubMed ID: 19207325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study.
    Levy RM; Redbord KP; Hanke CW
    J Am Acad Dermatol; 2008 Dec; 59(6):923-33. PubMed ID: 19022099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study.
    Orlando G; Guaraldi G; De Fazio D; Rottino A; Grisotti A; Blini M; De Santis G; Pedone A; Spaggiari A; Baccarani A; Vandelli M; De Paola M; Comelli D; Nardini G; Beghetto B; Squillace N; Esposito R
    AIDS Patient Care STDS; 2007 Nov; 21(11):833-42. PubMed ID: 18240893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience in the treatment of HIV-associated lipodystrophy.
    Nelson L; Stewart KJ
    J Plast Reconstr Aesthet Surg; 2008; 61(4):366-71. PubMed ID: 18023267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyacrylamide gel treatment of antiretroviral therapy-induced facial lipoatrophy in HIV patients.
    Mansor S; Breiting VB; Dahlstrøm K; Andersen AB; Andersen O; Christensen LH
    Aesthetic Plast Surg; 2011 Oct; 35(5):709-16. PubMed ID: 21359981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction and duration of effect with PLLA: a review of the literature.
    Palm MD; Goldman MP
    J Drugs Dermatol; 2009 Oct; 8(10 Suppl):s15-20. PubMed ID: 19891117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.